
REMODEL Trial Provides Mechanistic Rationale for Semaglutide in CKD
At the World Congress of Nephrology 2026 in Yokohama, Japan, growing attention is being paid not just to whether therapies improve outcomes in chronic kidney disease, but how they work at a mechanistic level. In this epi











